Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00979342 · ClinicalTrials.gov registry record · NA
Comparative Sedation Study of the MyoSure Hysteroscopic Tissue Removal System
A NA study, sponsored by Hologic.
- Completed
- Registry status
- NA
- Development phase
- 40
- Enrollment target
NCT00979342 is a NA study that has completed, run by Hologic. The registered enrollment target is 40 participants.
The verdict
NCT00979342, a NA study, has completed, sponsored by Hologic.
- COMPLETED
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
Study Summary
The purpose of this study is to develop a recommended local anesthetic protocol and post-treatment pain management regimen, in order to assure patient comfort during office-based treatment with the MyoSure Hysteroscopic Tissue Removal Device. Subject self-reported pain scores (as rated on an 11 point scale) will be compared at multiple time intervals between all treatment groups.
Interventions
- DEVICE Hysteroscopic Morcellator
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2009-11 |
| Est. Completion | 2010-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00979342
The ClinicalTrials.gov registry entry for NCT00979342 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Hologic, which has 21 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Hysteroscopic Morcellator is the first listed.
NCT00979342 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00979342 about?
NCT00979342 is a clinical study titled "Comparative Sedation Study of the MyoSure Hysteroscopic Tissue Removal System". The purpose of this study is to develop a recommended local anesthetic protocol and post-treatment pain management regimen, in order to assure patient comfort during office-based treatment with the MyoSure Hysteroscopic Tissue Removal Device. Subject self-reported pain scores (as rated on an 11 poin...
What is the current status of trial NCT00979342?
This trial is currently completed. It is a NA study. The enrollment target is 40 participants. The study started on 2009-11. Estimated completion is 2010-07.
What interventions are being tested in trial NCT00979342?
The interventions under investigation include: Hysteroscopic Morcellator (DEVICE).
Who is sponsoring clinical trial NCT00979342?
This trial is sponsored by Hologic, which has 21 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.